Search This Blog

Thursday, September 17, 2026

Kamada says KedRAB supply and capacity sufficient to meet rising U.S. demand

 

Kamada says KedRAB supply and capacity sufficient to meet rising U.S. demand after CDC flags higher rabies exposures

  • CDC report cites increased U.S. rabies exposures and anti-rabies immunoglobulin use, raising demand for KedRAB.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)